Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients Gul Alco et al, 2015, Oncol Lett CrossRef
Ki67 as a Biomarker of Prognosis and Prediction: Is it Ready for Use in Routine Pathology Practice? Constance Albarracin et al, 2014, Curr Breast Cancer Rep CrossRef
Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Miroslava Juríková et al, 2016, Acta Histochem CrossRef
Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study. Masaharu Seno et al, 2014, PLoS ONE CrossRef
Association of clinical, histopathological and immunohistochemical prognostic factors of invasive breast tumors and thermographic findings Zvonimir Zore et al, 2015, Infrared Physics & Technology CrossRef
MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer Cynthia Brito Lins Pereira et al, 2017, Clinical Breast Cancer CrossRef
Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients Li Ding et al, 2017, Bioengineered CrossRef
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma Ozgul Ekmekcioglu et al, 2013, Nuclear Medicine Communications CrossRef
Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer. Ibrahim Tekedereli et al, 2013, Mol Ther Nucleic Acids CrossRef
Clinical Significance of CK19 Negative Breast Cancer. Mamiko Fujisue et al, 2012, Cancers (Basel) CrossRef
Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study Rumiko Tashima et al, 2015, PLoS ONE CrossRef
Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression Yoshimi Ide et al, 2013, PLoS ONE CrossRef
Breast Cancer Subtype and Distant Recurrence after Ipsilateral Breast Tumor Recurrence Makoto Ishitobi et al, 2013, Ann Surg Oncol CrossRef
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients Fausto Petrelli et al, 2015, Breast Cancer Res Treat CrossRef
Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes Max Denis et al, 2016, PLoS ONE CrossRef
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR Makoto Ishitobi et al, 2014, Breast Cancer CrossRef
Pathological examination of breast cancer biomarkers: current status in Japan Shinobu Masuda, 2016, Breast Cancer CrossRef
A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age Jeanny Kwon et al, 2017, J Breast Cancer CrossRef
Survival time according to the year of recurrence and subtype in recurrent breast cancer Masahiro Nakano et al, 2015, The Breast CrossRef
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence Y. Okumura et al, 2015, European Journal of Surgical Oncology (EJSO) CrossRef
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence Eman Abdelzaher et al, 2015, Tumor Biol. CrossRef
Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer Han-Seong Kim et al, 2014, PLoS ONE CrossRef
Unmanipulated native fat exposed to high-energy diet, but not autologous grafted fat by itself, may lead to overexpression of Ki67 and PAI-1 Francisco Claro et al, 2015, SpringerPlus CrossRef
Assessment of the Cancer Risk of the Fat-Grafted Breast in a Murine Model Francisco Claro et al, 2016, ASJOUR CrossRef
Time to first tumor progression as a predictor of efficacy of continued treatment with trastuzumab beyond progression in human epidermal growth factor receptor 2-positive metastatic breast cancer Mitsuhiro Hayashi et al, 2011, Int J Clin Oncol CrossRef
Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients Young-Woo Kim et al, 2015, Exp Mol Med CrossRef
Role of Ki67 in predicting resistance to adjuvant tamoxifen in postmenopausal breast cancer patients. Heba M Elzawahry et al, 2013, J Egypt Natl Canc Inst CrossRef
The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index Nobuyuki Arima et al, 2016, J Clin Pathol CrossRef
Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab. Li Bian et al, 2014, Cancer Biol Ther CrossRef
FoxM1: Repurposing an oncogene as a biomarker Deeptashree Nandi et al, 2017, Seminars in Cancer Biology CrossRef
Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis Alberto Gallardo et al, 2017, Breast Cancer Res Treat CrossRef
Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information Zorka Inic et al, 2014, Clinical Medicine Insights: Oncology CrossRef
Stromal expression of CD10 in invasive breast carcinoma and its correlation with clinicopathological parameters Azza M. Rizk et al, 2017, Egyptian Journal of Pathology CrossRef
Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes Johannes Uhlig et al, 2017, Translational Oncology CrossRef
Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study. G Martelli et al, 2017, Eur J Surg Oncol CrossRef
Biological subtypes of breast cancer: Prognostic and therapeutic implications. Ozlem Yersal et al, 2014, World J Clin Oncol CrossRef
Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer REIKI NISHIMURA et al, 2014 CrossRef
MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma. Ludmila de F Valverde et al, 2018, Appl Immunohistochem Mol Morphol CrossRef
Automated digital image analysis and manual counting of Ki-67 proliferation index in patients with breast cancer Mervat M.F. El-Deftar et al, 2017, Egyptian Journal of Pathology CrossRef
Evaluation of Involvement of Axillary Lymph Nodes with Ki-67 Expression in Patients with Breast Cancer Mahdi Asadi et al, 2018, Int J Cancer Manag CrossRef
Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score Parker C. Wilson et al, 2018, Breast J CrossRef
Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting Ellen M. Langer et al, 2019, Cell Reports CrossRef
Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis Reiki Nishimura et al, 2011, World J Surg Onc CrossRef
Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients Manjiri M. Bakre et al, 2019, Cancer Med CrossRef
Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma Z. Chu et al, 2015, Japanese Journal of Clinical Oncology CrossRef
Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer Tímea Tőkés et al, 2019, Pathol. Oncol. Res. CrossRef
Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status Mehrdad Payandeh et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
Assessment of Ki-67 as a potential biomarker in patients with breast cancer Halla Mohamed Ragab et al, 2018, Journal of Genetic Engineering and Biotechnology CrossRef
Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis. Qiang Wu et al, 2019, Front Oncol CrossRef
Prognostic value of the Ki-67 proliferation index in patients with triple negative breast carcinoma. Preliminary report Ángel Fernández et al, 2020, Invest Clin CrossRef
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools Hidemi Okuma et al, 2020, PLoS ONE CrossRef
B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients Monika Pizon et al, 2018, Int J Oncol CrossRef
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors Nobuyuki Arima et al, 2018, Oncol Lett CrossRef
Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort Heein Jo et al, 2020, Korean J Clin Oncol CrossRef
Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
HER2-positive pure mucinous breast carcinoma Xingjuan Zhao et al, 2020 CrossRef
Cancer progression and the invisible phase of metastatic colonization. Christoph A Klein, 2020, Nat Rev Cancer CrossRef
A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study Mowafak Masoud Bahaddin, 2020, Annals of Medicine and Surgery CrossRef
Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer Nuri Lee et al, 2020, IJMS CrossRef
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function Milad Rouhimoghadam et al, 2020, Front. Endocrinol. CrossRef
Postmenopausal Breast Cancer in Women, Clinical and Epidemiological Factors Related to the Molecular Subtype: A Retrospective Cohort Study in a Single Institution for 13 Years. Follow-Up Data Cristina Marinela Oprean et al, 2020, IJERPH CrossRef
High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers Simon J. Anderhub et al, 2019, Mol Cancer Ther CrossRef
Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2) Homa Seyedmirzaei et al, 2021, J Oncol Pharm Pract CrossRef
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience Mirco Pistelli et al, 2021, Journal of Oncology CrossRef
Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer Nsreen R. A. Mohamadien et al, 2021 CrossRef
Correlation between ER, PR, HER-2, and Ki-67 with the risk of bone metastases detected by bone scintigraphy in breast cancer patients: A cross sectional study Hanif Afkari et al, 2021, Annals of Medicine and Surgery CrossRef
Self-Assembling Polypeptide Hydrogels as a Platform to Recapitulate the Tumor Microenvironment Dariusz Lachowski et al, 2021, Cancers CrossRef
Expression of Ki67 in Triple Negative Breast Carcinoma and Its Correlation with Clinicopathological Variables – A Study from a Tertiary Care Center in Thrissur, Kerala Reshma Gopalakrishnan et al, 2021, jebmh CrossRef
Determination of the risk factors for breast cancer survival using the Bayesian method, Yazd, Iran Vida Pahlevani et al, 2021, Adv Biomed Res CrossRef
Slow degrading Mg-based materials induce tumor cell dormancy on an osteosarcoma-fibroblast coculture model Philipp Globig et al, 2021, Bioactive Materials CrossRef
A review of prognostic and predictive biomarkers in breast cancer Elaheh Tarighati et al, 2022, Clin Exp Med CrossRef
Feasibility of Shear Wave Elastography Imaging for Evaluating the Biological Behavior of Breast Cancer Chaoxu Liu et al, 2022, Front. Oncol. CrossRef
MOLECULAR SUBTYPES OF BREAST CANCER Michael Abiodun Adeyanju, 2022, ijsr CrossRef
Outcomes of Breast-Conserving Surgery Plus Radiation vs Mastectomy for All Subtypes of Early-Stage Breast Cancer: Analysis of More Than 200,000 Women Quyen D Chu et al, 2022 CrossRef
Preclinical Therapeutic Assessment of a New Chemotherapeutics [Dichloro(4,4’-Bis(2,2,3,3-Tetrafluoropropoxy) Methyl)-2,2’-Bipryridine) Platinum] in an Orthotopic Patient-Derived Xenograft Model of Triple-Negative Breast Cancers Tzu-Chun Kan et al, 2022, Pharmaceutics CrossRef
Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients null Vu Hong Thang et al, 2015, J. Anal. Oncol. CrossRef
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura et al, 2013, Oncology CrossRef
Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients Najah Mighri et al, 2022, PLoS ONE CrossRef
Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis Wei-Xiang Qi et al, 2022, Journal of Oncology CrossRef
Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression Esraa Magdy Abdelraouf et al, 2022, Life Sciences CrossRef
Breast MRI Segmentation and Ki-67 High- and Low-Expression Prediction Algorithm Based on Deep Learning Yuan-Zhe Li et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
Comparison of Clinical, Histopathological, and Survival Outcomes of Pure and Mixed Mucinous Breast Carcinoma Ahmet Cem Esmer et al, 2022, Indian J Surg CrossRef
Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study Gabriele Martelli et al, 2022 CrossRef
Satellite Noncoding RNAs (ncRNA) as Cancer Biomarkers? New Insights from FA-SAT ncRNA Molecular and Clinical Profiles in Feline Mammary Tumors Daniela Ferreira et al, 2022, OMICS: A Journal of Integrative Biology CrossRef